Showing results (11-20 of 301) with videos related to

Sort By:
Pageof 31
Autoimmunity Reviews|April 9, 2019
The pipeline of targeted therapies under clinical development for primary Sjögren's syndrome: A systematic review of trialsRenaud Felten, Florence Scher, Jean Sibilia, et al.
Annals of the Rheumatic Diseases|April 17, 2019
The world-wide burden of musculoskeletal diseases: a systematic analysis of the World Health Organization Burden of Diseases DatabaseEden Sebbag, Renaud Felten, Flora Sagez, et al.
Autoimmunity Reviews|August 9, 2024
The pipeline of immunomodulatory therapies in polymyalgia rheumatica and giant cell arteritis: A systematic review of clinical trialsLou Kawka, Baptiste Chevet, Laurent Arnaud, et al.
Joint Bone Spine|January 30, 2021
Rheumatic presentations of Guillain-Barré syndrome as a diagnostic challenge: A case seriesStanislas Demuth, Renaud Felten, Christelle Sordet, et al.
Autoimmunity Reviews|January 10, 2020
Characterization of auto-immune hepatitis associated with the use of anti-TNFα agents: An analysis of 389 cases in VigiBaseOlivier Vollmer, Renaud Felten, Philippe Mertz, et al.
Autoimmunity Reviews|June 10, 2018
The 2018 pipeline of targeted therapies under clinical development for Systemic Lupus Erythematosus: a systematic review of trialsRenaud Felten, Elida Dervovic, François Chasset, et al.
Vaccines|January 22, 2022
Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: Results from the Nationwide VAXILONG StudyMarc Scherlinger, Luc Pijnenburg, Emmanuel Chatelus, et al.
Therapeutic Advances in Musculoskeletal Disease|January 6, 2021
Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stageJulien Blaess, Julia Walther, Arthur Petitdemange, et al.
Best Practice & Research. Clinical Rheumatology|August 26, 2023
New and future therapies: Changes in the therapeutic armamentarium for SLEAnca Askanase, Leila Khalili, Wei Tang, et al.
Joint Bone Spine|August 28, 2023
Type 1 interferons: A target for immune-mediated inflammatory diseases (IMIDs)Alexis Mathian, Renaud Felten, Marta E Alarcon-Riquelme, et al.
Pageof 31